References
- Simmons A, Wierenga C, Stein OY, et al. Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder. Psychiatry Res. 2015;233:394–401.
- Joshi M, Gat GV, Mehta SR. Patent no. 8,277,840 B2. United States; 2012.
- Shrestha S, Khanal DP, Thapa P. Development and evaluation of alprazolam controlled release tablets. J Manmohan Memorial Inst Health Sci. 2014;1:8–23.
- Avadi MR, Hedayatzadeh M. Preparation and in vitro characterization of alprazolam extended-release tablets using HPMC 4000cps. J Pharm Health Sci. 2016;4:43–52.
- Isbister GK, O'Regan L, Sibbritt D, et al. Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol. 2004;58:88–95.
- Sweetman SC. Martindale: the complete drug reference. 33rd ed. London (UK): Pharmaceutical Press; 2002.
- Deacon RM, Nielsen S, Leung S, et al. Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling. Int J Drug Policy. 2016;36:104–111.
- Soler LI, Boix A, Lauroba J, et al. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization. Drug Dev Ind Pharm. 2012;38:1171–1178.
- Maji P, Gandhi A, Jana S, et al. Preparation and characterization of maleic anhydride cross-linked chitosan-polyvinyl alcohol hydrogel matrix transdermal patch. J PharmaSciTech. 2013;2:62–67.
- Nounou MI, El-Khordagui LK, Khalafallah NA, et al. Liposomal formulation for dermal and transdermal drug delivery: past, present and future. DDF. 2008;2:9–18.
- Skalko-Basnet N, Pavelic Z, Becirevic-Lacan M. Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method. Drug Dev Ind Pharm. 2000;26:1279–1284.
- Vyas SP, Rawat M, Rawat A, et al. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha. Drug Dev Ind Pharm. 2006;32:699–707.
- Barenholz Y. Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res. 2003;13:1–8.
- Kamps JA, Scherphof GL. Liposomes in biological systems. In: Torchilin V, Weissing V, editors. Liposomes: a practical approach. Oxford (UK): Oxford University Press; 2003. p. 267–286.
- Panwar P, Pandey B, Lakhera PC, et al. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine. 2010;5:101–108.
- Fan M, Xu S, Xia S, et al. Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. Eur Food Res Technol. 2008;227:167–174.
- Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–252.
- Jaafar-Maalej C, Diab R, Andrieu V, et al. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20:228–243.
- Meure LA, Foster NR, Dehghani F. Conventional and dense gas techniques for the production of liposomes: a review. AAPS PharmSciTech. 2008;9:798–809.
- Vemuri S, Yu C, Wangsatorntanakun V, et al. Large scale production of liposomes by microfluidizer. Drug Dev Ind Pharm. 1990;16:2243–2256.
- Sonar S, D'Souza SE, Mishra KP. A simple one-step protocol for preparing small-sized doxorubicin-loaded liposome. J Environ Pathol Toxicol Oncol. 2008;27:181–189.
- Tan K, Sivakumar M. Response surface methodology, an effective strategy in the optimization of the generation of curcumin-loaded micelles. Asia-Pacific J Chem Eng. 2012;7:125–133.
- Ruckmani K, Sankar V, Sivakumar M. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. J Biomed Nanotechnol. 2010;6:43–51. 2010.
- Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102.
- Lasic DD. The mechanism of vesicle formation. Biochem J. 1988;256:1–11.
- Sezer AD, Akbuga J, Bas AL. In vitro evaluation of enrofloxacin-loaded MLV liposomes. Drug Deliv. 2007;14:47–53.
- Kesisoglou F, Zhou SY, Niemiec S, et al. Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model. Pharm Res. 2005;22:1320–1330.
- Epstein H, Gutman D, Cohen-Sela E, et al. Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization. AAPS J. 2008;10:505–515.